DOCSLIB.ORG

HL7 V2.5 Appendix A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
HL7 V2.5 Appendix A A. Data Definition Tables A.1 APPENDIX A CONTENTS A.1 APPENDIX A CONTENTS....................................................................................................................... A-1 A.2 INTRODUCTION ...................................................................................................................................... A-1 A.3 MESSAGE TYPES..................................................................................................................................... A-2 A.4 SEGMENTS................................................................................................................................................ A-5 A.5 HL7 AND USER-DEFINED TABLES - ALPHABETIC SORT.......................................................... A-10 A.6 HL7 AND USER-DEFINED TABLES - NUMERIC SORT ................................................................ A-24 A.7 DATA ELEMENT NAMES................................................................................................................... A-189 A.2 INTRODUCTION The HL7 specifications were prepared using a data dictionary database. Certain outputs from that database are included in the chapters that define the abstract messages. These outputs list the data fields and field notes associated with a segment. Other Data Dictionary outputs are included here to comprise appendix A. These include: • a list of the message types that comprise the HL7 protocol • a list of the segment IDs and segment names • a list of each data element organized alphabetically by name • a list of the IDs and names of all tables of coded values • a cross reference of table IDs vs. data element names • a list of the contents of each table • a list of all data element names. Health Level Seven, Version 2.6 © 2007. All rights reserved. Page A-1 Final Standard. November 2007. Appendix A: Data Definition Tables A.3 MESSAGE TYPES Message Description Chapter(s) ACK General acknowledgment message 2.13.1 ADT ADT message 3.3.1, 3.3.2, 3.3.3, 3.3.4, 3.3.5, 3.3.6, 3.3.7, 3.3.8, 3.3.9, 3.3.10, 3.3.11, 3.3.12, 3.3.13, 3.3.14, 3.3.15, 3.3.16, 3.3.17, 3.3.18, 3.3.20, 3.3.21, 3.3.22, 3.3.23, 3.3.24, 3.3.25, 3.3.26, 3.3.27, 3.3.28, 3.3.29, 3.3.30, 3.3.31, 3.3.32, 3.3.33, 3.3.34, 3.3.35, 3.3.36, 3.3.37, 3.3.38, 3.3.39, 3.3.40, 3.3.41, 3.3.42, 3.3.43, 3.3.44, 3.3.45, 3.3.46, 3.3.47, 3.3.48, 3.3.49, 3.3.50, 3.3.51, 3.3.52, 3.3.53, 3.3.54, 3.3.55, 3.3.60, 3.3.61, 3.3.62 BAR Add/change billing account 6.4.1, 6.4.2, 6.4.5, 6.4.6, 6.4.7, 6.4.9 BPS Blood product dispense status message 4.20.3 BRP Blood product dispense status acknowledgement 4.20.4 message BRT Blood product transfusion/disposition 4.20.6 acknowledgement message BTS Blood product transfusion/disposition message 4.20.5 CRM Clinical study registration message 7.7.1 CSU Unsolicited study data message 7.7.2 DFT Detail financial transactions 6.4.3, 6.4.8 EAC Automated equipment command message 13.3.7 EAN Automated equipment notification message 13.3.9 EAR Automated equipment response message 13.3.8 EHC Health Care Invoice 16.3.1, 16.3.2, 16.3.5, 16.3.6, 16.3.7, 16.3.8, 16.3.9, 16.3.10, 16.3.11, 16.3.14 ESR Automated equipment status update 13.3.2 acknowledgment message ESU Automated equipment status update message 13.3.1 INR Automated equipment inventory request message 13.3.6 INU Automated equipment inventory update message 13.3.5 LSR Automated equipment log/service request message 13.3.13 LSU Automated equipment log/service update message 13.3.12 MDM Medical document management 9.5.1, 9.5.2, 9.5.3, 9.5.4, 9.5.5, 9.5.6, 9.5.7, 9.5.8, 9.5.9, 9.5.10, 9.5.11 MFN Master files notification 8.4.1, 8.7.1, 8.8.2, 8.10.1, 8.9.1, 8.11.1, 8.8.3, 8.8.4, 8.8.5, 8.8.6, 8.8.7, 8.4.2, 8.4.3, 8.12.1, 8.12.2, 8.13.1 NMD Application management data message 14.3.2 NMQ Application management query message 14.3.1 OMB Blood product order message 4.20.1 OMD Dietary order 4.7.1 OMG General clinical order message 4.4.4 Page A-2 Health Level Seven, Version 2.6 © 2007. All rights reserved. November 2007. Final Standard. Appendix A: Data Definition Tables Message Description Chapter(s) OMI Imaging order 4.4.12 OML Laboratory order message 4.4.6, 4.4.8, 4.4.10 OMN Non-stock requisition order message 4.10.3 OMP Pharmacy/treatment order message 4.13.3 OMS Stock requisition order message 4.10.1 OPL Population/Location-Based Laboratory Order 4.4.14 Message OPR Population/Location-Based Laboratory Order 4.4.15 Acknowledgment Message OPU Unsolicited Population/Location-Based Laboratory 7.3.10 Observation Message ORB Blood product order acknowledgement message 4.20.2 ORD Dietary order acknowledgment message 4.7.2 ORF Query for results of observation 7.3.3 ORG General clinical order acknowledgment message 4.4.5 ORI Imaging order acknowledgement message 4.4.13 ORL Laboratory acknowledgment message (unsolicited) 4.4.7, 4.4.9, 4.4.11 ORM Pharmacy/treatment order message 4.4.1 ORN Non-stock requisition - General order 4.10.4 acknowledgment message ORP Pharmacy/treatment order acknowledgment message 4.13.4 ORR General order response message response to any 4.4.2 ORM ORS Stock requisition - Order acknowledgment message 4.10.2 ORU Unsolicited transmission of an observation message 7.3.1, 7.3.4, 7.3.5, 7.3.6 OSQ Query response for order status 4.4.3 OUL Unsolicited laboratory observation message 7.3.2, 7.3.7, 7.3.8, 7.3.9 PEX Product experience message 7.11.1 PGL Patient goal message 12.3.1 PIN Patient insurance information 11.3.7 PMU Add personnel record 15.3.1, 15.3.2, 15.3.3, 15.3.4, 15.3.5, 15.3.6, 15.3.8, 15.3.9 PPG Patient pathway message (goal-oriented) 12.3.4 PPP Patient pathway message (problem-oriented) 12.3.3 PPR Patient problem message 12.3.2 PPT Patient pathway goal-oriented response 12.3.12 PPV Patient goal response 12.3.8 PRR Patient problem response 12.3.6 PTR Patient pathway problem-oriented response 12.3.10 Health Level Seven, Version 2.5.1 © 2007. All rights reserved. Page A-3 Final Standard. January 2007. Appendix A: Data Definition Tables Message Description Chapter(s) QBP Query by parameter 16.3.3, 16.3.12, 5.4.1, 5.4.2, 5.4.3, 3.3.56, 3.3.57, 3.3.58, 3.3.59, 15.3.7, 4.13.20, 4.6.2, 5.9.7.2, 5.9.7.1, 5.9.6.1, 5.9.1.1.1, 5.9.1.2.1, 5.9.2.1.1, 5.9.2.4, 5.9.3.1.1, 5.9.3.2.1, 5.9.4.1.1, 5.9.5.1, 5.3.1.2, 8.4.5.1 QCN Cancel query 5.4.6 QRY Query, original mode 3.3.19, 12.3.5, 12.3.7, 12.3.9, 12.3.11, 4.13.15, 4.13.16, 4.13.17, 4.13.18, 4.13.19, 7.3.3, 9.8.1 QSB Create subscription 5.4.4, 5.7.3.1 QSX Cancel subscription/acknowledge message 5.4.7 QVR Query for previous events 5.4.5 RAR Pharmacy/treatment administration information 4.13.16 RAS Pharmacy/treatment administration message 4.13.11 RDE Pharmacy/treatment encoded order message 4.13.5, 4.13.13 RDS Pharmacy/treatment dispense message 4.13.7 RDY Display based response 5.4.3, 5.9.6.1, 5.9.5.1 REF Patient referral 11.5.1 RER Pharmacy/treatment encoded order information 4.13.18 RGR Pharmacy/treatment dose information 4.13.19 RGV Pharmacy/treatment give message 4.13.9 ROR Pharmacy/treatment order response 4.13.15 RQA Request patient authorization 11.4.1 RQC Request clinical information 11.3.5, 11.3.6 RQI Request patient information 11.3.1, 11.3.2, 11.3.3 RQP Request patient demographics 11.3.4 RRA Pharmacy/treatment administration acknowledgment 4.13.12 message RRD Pharmacy/treatment dispense acknowledgment 4.13.8 message RRE Pharmacy/treatment encoded order acknowledgment 4.13.6, 4.13.14 message RRG Pharmacy/treatment give acknowledgment message 4.13.10 RSP Segment pattern response 5.4.1, 3.3.56, 3.3.57, 3.3.58, 3.3.59, 15.3.7, 4.13.20, 5.9.1.1.1, 5.3.1.2, 5.9.1.2.1, 5.9.2.1.1, 5.9.2.4 RTB Tabular response 5.4.2, 4.6.2, 5.9.7.2, 5.9.7.1, 5.9.3.1.1, 5.9.3.2.1, 5.9.4.1.1 SCN Notification of Anti-Microbial Device Cycle Data 17.6.5 SDN Notification of Anti-Microbial Device Data 17.6.4 SDR Sterilization anti-microbial device data request 17.5.4 SIU Schedule information unsolicited 10.4 SLN Notification of New Sterilization Lot 17.6.2, 17.6.3 SLR Sterilization lot request 17.5.1, 17.5.2 Page A-4 Health Level Seven, Version 2.6 © 2007. All rights reserved. November 2007.
Load more

Recommended publications
  • MS Hatch-Waxman PTE REQUEST for EXTENSION of PATENT
    Docket No.: 029420.0155-US02 (PATENT) IN THE UNITED STATES PATENT AND TRADEMARK OFFICE In re United States Patent of: Alan J. Korman, et aL. Patent No.: 7,605,238 Issued: October 20, 2009 For: HUMAN CTLA-4 ANTIBODIES MS Hatch-Waxman PTE Commissioner for Patents Offce of Patent Legal Administration Room MDW 7D55 600 Dulany Street (Madison Building) Alexandria, VA 223 14 REQUEST FOR EXTENSION OF PATENT TERM UNDER 35 U.S.C. §156 Sir: Pursuant to 35 U.S.C. §156 and 37 C.F.R. §§1.710-1.791, Medarex, Inc., the current address of which is Route 206 and Province Line Road, Princeton, New Jersey 08540 ("Applicant" or "Medarex"), hereby requests an extension of U.S. Patent No. 7,605,238 (the "'238 patent"). As permitted by 37 C.F.R. §1.785(b) and MPEP §2761, Applicant is concurrently fiing a request for patent term extension of U.S. Patent No. 6,984,720 based upon the same regulatory review period. Medarex represents that it is the owner and assignee of the entire interest in and to Letters Patent of the United States No. 7,605,238 (Exhibit 1) granted to Alan J. Korman, Edward L. Halk, Nils Lonberg, Yashwant M. Deo and Tibor P. Keler (the "inventors") on October 20, 2009, for "Human CTLA-4 Antibodies and Their Uses" by virtue of an assignment from the DC; 3983891.1 Patent No.: 7,605,238 - 2- Docket No.: 029420.0155-US02 Alan J. Korman, Edward L. Halk and Nils Lonberg to Medarex, recorded in the United States Patent and Trademark Offce ("PTO") on March 6, 2003 at Reel 013817, Frame 0628 and an assignment from Yashwant M.
    [Show full text]
  • Mysql 5.6 Error Message Reference Abstract
    MySQL 5.6 Error Message Reference Abstract This is the MySQL 5.6 Error Message Reference. It lists all error messages produced by server and client programs in MySQL 5.6. This document accompanies Error Messages and Common Problems, in MySQL 5.6 Reference Manual. For help with using MySQL, please visit the MySQL Forums, where you can discuss your issues with other MySQL users. Document generated on: 2021-09-23 (revision: 70881) Table of Contents Preface and Legal Notices ............................................................................................................ v 1 MySQL Error Reference ............................................................................................................ 1 2 Server Error Message Reference ............................................................................................... 3 3 Client Error Message Reference ............................................................................................... 73 4 Global Error Message Reference .............................................................................................. 79 Index .......................................................................................................................................... 83 iii iv Preface and Legal Notices This is the MySQL 5.6 Error Message Reference. It lists all error messages produced by server and client programs in MySQL 5.6. Legal Notices Copyright © 1997, 2021, Oracle and/or its affiliates. This software and related documentation are provided under a license
    [Show full text]
  • B2bi 2.5 Support Reference Catalog 3 Accessibility
    B2Bi Version 2.5 April 2019 Support Reference Catalog Copyright © 2019 Axway All rights reserved. This documentation describes the following Axway software: Axway B2Bi 2.5 No part of this publication may be reproduced, transmitted, stored in a retrieval system, or translated into any human or computer language, in any form or by any means, electronic, mechanical, magnetic, optical, chemical, manual, or otherwise, without the prior written permission of the copyright owner, Axway. This document, provided for informational purposes only, may be subject to significant modification. The descriptions and information in this document may not necessarily accurately represent or reflect the current or planned functions of this product. Axway may change this publication, the product described herein, or both. These changes will be incorporated in new versions of this document. Axway does not warrant that this document is error free. Axway recognizes the rights of the holders of all trademarks used in its publications. The documentation may provide hyperlinks to third-party web sites or access to third-party content. Links and access to these sites are provided for your convenience only. Axway does not control, endorse or guarantee content found in such sites. Axway is not responsible for any content, associated links, resources or services associated with a third-party site. Axway shall not be liable for any loss or damage of any sort associated with your use of third-party content. Contents Accessibility 4 Accessibility features of B2Bi 4 Keyboard
    [Show full text]
  • Australian Pathology Messaging - Localisation of HL7 Version 2.4
    Australian Pathology Messaging - Localisation of HL7 Version 2.4 Sponsored by: The Royal College of Pathologists of Australasia (RCPA)/HL7 Australia HL7 Australia Orders and Observations Co-chairs: Michael Legg, RCPA and Michael Legg & Associates Andrew McIntyre, Medical Objects Editors Eric Browne, Montage Systems David McKillop, Australian Digital Health Agency Jared Davison, Medical Objects Donna Moore, RCPA Joint Copyright © 2016 Health Level Seven International ® and Health Level Seven Australia Inc ABN 35 556 933 588 ALL RIGHTS RESERVED. The reproduction of this material in any form is strictly forbidden without the written permission of the publishers. HL7 International and Health Level Seven are registered trademarks of Health Level Seven International. Questions or comments regarding this document should be directed to Michael Legg ( [email protected]) or Andrew McIntyre ( a [email protected]) Table of Contents 1 Introduction 2 Patient Administration for Pathology 3 Datatypes 4 Observation Reporting 5 Observation Ordering 6 Identifiers Appendix 1 Parsing HL7v2 Appendix 2 Rendering of reports and display format Appendix 3 Common Errors Appendix 4 HL7 Code Tables Appendix 5 Conformance statements Appendix 6 Example messages Index of Tables Table 1-1. Message Element Attributes Table 1-2. Usage Conformance Testing Recommendations Table 6-1. Identifiers examples Table of Figures Figure 2-1. HL7 message segments Figure 3-1. HL7 data types by category Figure 3-2. Subcomponents of order sequences Figure 5-1. RU and RO usage (example) Figure 5-2. RQ and RO usage (example) Figure 5-3. Example of two child orders 1 Introduction Australian Pathology Messaging - Localisation of HL7 Version 2.4, Release 1 is the Australian localisation of the HL7 V2 Laboratory ordering and result reporting specification.
    [Show full text]
  • ISO Basic Latin Alphabet
    ISO basic Latin alphabet The ISO basic Latin alphabet is a Latin-script alphabet and consists of two sets of 26 letters, codified in[1] various national and international standards and used widely in international communication. The two sets contain the following 26 letters each:[1][2] ISO basic Latin alphabet Uppercase Latin A B C D E F G H I J K L M N O P Q R S T U V W X Y Z alphabet Lowercase Latin a b c d e f g h i j k l m n o p q r s t u v w x y z alphabet Contents History Terminology Name for Unicode block that contains all letters Names for the two subsets Names for the letters Timeline for encoding standards Timeline for widely used computer codes supporting the alphabet Representation Usage Alphabets containing the same set of letters Column numbering See also References History By the 1960s it became apparent to thecomputer and telecommunications industries in the First World that a non-proprietary method of encoding characters was needed. The International Organization for Standardization (ISO) encapsulated the Latin script in their (ISO/IEC 646) 7-bit character-encoding standard. To achieve widespread acceptance, this encapsulation was based on popular usage. The standard was based on the already published American Standard Code for Information Interchange, better known as ASCII, which included in the character set the 26 × 2 letters of the English alphabet. Later standards issued by the ISO, for example ISO/IEC 8859 (8-bit character encoding) and ISO/IEC 10646 (Unicode Latin), have continued to define the 26 × 2 letters of the English alphabet as the basic Latin script with extensions to handle other letters in other languages.[1] Terminology Name for Unicode block that contains all letters The Unicode block that contains the alphabet is called "C0 Controls and Basic Latin".
    [Show full text]
  • Contribution to the Federation of the Asynchronous Smartsantander Service Layer Within the European Fed4fire Context
    UNIVERSITY OF PADOVA Master Degree in Telecommunication Engineering Contribution to the Federation of the asynchronous SmartSantander service layer within the European Fed4FIRE context. Advisor Student Michele Zorzi ala Leo Turi Co-Advisors Luis Muñoz Pablo Sotres Department of Information Engineering Academic Year 2014/2015 13th October, 2015 To my parents. For all they do, all they go through while I am away, and for all the love they give me. Every time, everywhere I am. I love you. To Pippo, Matt, Fede, Gi and Eleo. And to Gabb and Marco, newly found. You’re the brothers and sisters I never had. I’m glad I met you all. To the "malvagi", our beautiful and varied TLC group. I hope we won’t lose contact in the next years, for I would miss you all deeply. You were the best classmates ever. To all the guys of the TLMAT lab: JuanRa, Rafa, Carmen, Luisco, David, Jabo, Javi, Laura, Nacho, Pablo Martinez y Pablo Garrido (el Aleman!), Vero, Jose, Jesus. To Ramon Aguero, Luis Sánchez and Jorge. You were the warmest hosts I could ever find. And, last but not least, To Pablo Sotres, who was my tutor at Unican, helped me write my thesis, and always found time to assist me (Sundays and Holidays as well). I’m happy your eternal cough ceased way before I left. ∼ You have my deepest thanks. Finally, I’d like to acknowledge the guide of Prof. Zorzi and Prof. Muñoz. Their words and trust have been fundamental during this important experience. “It’s the questions we can’t answer that teach us the most.
    [Show full text]
  • The File Cmfonts.Fdd for Use with Latex2ε
    The file cmfonts.fdd for use with LATEX 2".∗ Frank Mittelbach Rainer Sch¨opf 2019/12/16 This file is maintained byA theLTEX Project team. Bug reports can be opened (category latex) at https://latex-project.org/bugs.html. 1 Introduction This file contains the external font information needed to load the Computer Modern fonts designed by Don Knuth and distributed with TEX. From this file all .fd files (font definition files) for the Computer Modern fonts, both with old encoding (OT1) and Cork encoding (T1) are generated. The Cork encoded fonts are known under the name ec fonts. 2 Customization If you plan to install the AMS font package or if you have it already installed, please note that within this package there are additional sizes of the Computer Modern symbol and math italic fonts. With the release of LATEX 2", these AMS `extracm' fonts have been included in the LATEX font set. Therefore, the math .fd files produced here assume the presence of these AMS extensions. For text fonts in T1 encoding, the directive new selects the new (version 1.2) DC fonts. For the text fonts in OT1 and U encoding, the optional docstrip directive ori selects a conservatively generated set of font definition files, which means that only the basic font sizes coming with an old LATEX 2.09 installation are included into the \DeclareFontShape commands. However, on many installations, people have added missing sizes by scaling up or down available Metafont sources. For example, the Computer Modern Roman italic font cmti is only available in the sizes 7, 8, 9, and 10pt.
    [Show full text]
  • Ibuprofen: Pharmacology, Therapeutics and Side Effects
    Ibuprofen: Pharmacology, Therapeutics and Side Effects K.D. Rainsford Ibuprofen: Pharmacology, Therapeutics and Side Effects K.D. Rainsford Biomedical Research Centre Sheffield Hallam University Sheffield United Kingdom ISBN 978 3 0348 0495 0 ISBN 978 3 0348 0496 7 (eBook) DOI 10.1007/978 3 0348 0496 7 Springer Heidelberg New York Dordrecht London Library of Congress Control Number: 2012951702 # Springer Basel 2012 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
    [Show full text]
  • Oracle® Database Installation Guide
    Oracle® Database Installation Guide 18c for Microsoft Windows E83888-01 August 2018 Oracle Database Installation Guide, 18c for Microsoft Windows E83888-01 Copyright © 1996, 2018, Oracle and/or its affiliates. All rights reserved. Primary Authors: Tanaya Bhattacharjee, Sunil Surabhi Contributing Authors: Prakash Jashnani, Mark Bauer, Bharathi Jayathirtha Contributors: Barb Glover, Eric Belden, Sudip Datta, David Friedman, Alex Keh, Peter LaQuerre, Rich Long, Matt McKerley, Sham Rao Pavan, Hanlin Qian, Sujatha Tolstoy, Sergiusz Wolicki, Sue Mavris, Mohammed Shahnawaz Quadri, Vishal Saxena, Krishna Itikarlapall, , Santanu Datta, Christian Shay, Aneesh Khanderwal, Michael Coulter, Robert Achacoso, Malai Stalin, David Price, Ramesh Chakravarthula This software and related documentation are provided under a license agreement containing restrictions on use and disclosure and are protected by intellectual property laws. Except as expressly permitted in your license agreement or allowed by law, you may not use, copy, reproduce, translate, broadcast, modify, license, transmit, distribute, exhibit, perform, publish, or display any part, in any form, or by any means. Reverse engineering, disassembly, or decompilation of this software, unless required by law for interoperability, is prohibited. The information contained herein is subject to change without notice and is not warranted to be error-free. If you find any errors, please report them to us in writing. If this is software or related documentation that is delivered to the U.S. Government or anyone licensing it on behalf of the U.S. Government, then the following notice is applicable: U.S. GOVERNMENT END USERS: Oracle programs, including any operating system, integrated software, any programs installed on the hardware, and/or documentation, delivered to U.S.
    [Show full text]
  • Latex2ε Font Selection
    LATEX 2" font selection c Copyright 1995{2000, LATEX3 Project Team. All rights reserved. 2 September 2000 Contents 1 Introduction 2 A 1.1 LTEX 2" fonts . 2 1.2 Overview . 2 1.3 Further information . 3 2 Text fonts 4 2.1 Text font attributes . 4 2.2 Selection commands . 6 2.3 Internals . 7 2.4 Parameters for author commands . 8 2.5 Special font declaration commands . 9 3 Math fonts 10 3.1 Math font attributes . 10 3.2 Selection commands . 11 3.3 Declaring math versions . 12 3.4 Declaring math alphabets . 12 3.5 Declaring symbol fonts . 13 3.6 Declaring math symbols . 14 3.7 Declaring math sizes . 16 4 Font installation 16 4.1 Font definition files . 16 4.2 Font definition file commands . 16 4.3 Font file loading information . 18 4.4 Size functions . 18 5 Encodings 20 5.1 The fontenc package . 20 5.2 Encoding definition file commands . 20 5.3 Default definitions . 23 5.4 Encoding defaults . 24 5.5 Case changing . 25 1 6 Miscellanea 25 6.1 Font substitution . 25 6.2 Preloading . 26 6.3 Accented characters . 26 6.4 Naming conventions . 27 7 If you need to know more . 28 1 Introduction A This document describes the new font selection features of the LTEX Document Preparation System. It is intended for package writers who want to write font- loading packages similar to times or latexsym. This document is only a brief introduction to the new facilities and is intended A for package writers who are familiar with TEX fonts and LTEX packages.
    [Show full text]
  • SAP IQ Administration: Unstructured Data Analytics Company
    USER GUIDE | INTERNAL SAP IQ 16.1 SP 03 Document Version: 1.0.0 – 2018-11-20 SAP IQ Administration: Unstructured Data Analytics company. All rights reserved. All rights company. affiliate THE BEST RUN 2020 SAP SE or an SAP SE or an SAP SAP 2020 © Content 1 SAP IQ Administration: Unstructured Data Analytics.................................5 2 Introduction to Unstructured Data Analytics.......................................6 2.1 Audience...................................................................6 2.2 The Unstructured Data Analytics Option.............................................6 Full Text Searching..........................................................7 2.3 Compatibility................................................................7 2.4 Conformance to Standards......................................................8 3 TEXT Indexes and Text Configuration Objects...................................... 9 3.1 TEXT Indexes................................................................9 Comparison of WD and TEXT Indexes........................................... 10 Creating a TEXT Index Using Interactive SQL.......................................11 Guidelines for TEXT Index Size Estimation........................................ 12 TEXT Index Restrictions.....................................................12 Displaying a List of TEXT Indexes Using Interactive SQL...............................13 Editing a TEXT Index Using Interactive SQL........................................14 Modifying the TEXT Index Location Using Interactive
    [Show full text]
  • Pharmacological Evaluation of Novel Dimers of an Arylpropionic Acid Class of Non-Selective Cyclooxygenase Inhibitors
    Halimi et al Tropical Journal of Pharmaceutical Research February 2017; 16 (2): 327-336 ISSN: 1596-5996 (print); 1596-9827 (electronic) © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. Available online at http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v16i2.10 Original Research Article Pharmacological evaluation of novel dimers of an arylpropionic acid class of non-selective cyclooxygenase inhibitors Syed Muhammad Ashhad Halimi1*, Muhammad Saeed1, Safiullah1 and Khalid Muhammed Khan2 1Department of Pharmacy, University of Peshawar, Peshawar 25120, 2H.E.J. International Centre for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi 75270, Pakistan *For correspondence: Email: [email protected]; Tel: +92 91 9216750; Fax: +92 91 9218318 Received: 4 August 2016 Revised accepted: 5 January 2017 Abstract Purpose: To explore and identify cyclooxygenase (COX) inhibitors with optimal potency and efficacy using an arylpropionic acid class of drugs as lead molecules. Methods: The selected lead molecules were dimerised through chemical processes (reflux condensation) and characterised in terms of structural properties using infrared, proton nuclear magnetic resonance, electron impact mass spectrometry, and elemental analysis techniques. The molecules were evaluated pharmacologically for acute toxicity and anti-inflammatory (carrageenan- induced paw oedema test), analgesic (acetic acid-induced writhing test in mice), and antipyretic (Brewer’s yeast-induced pyrexia test in mice) activities against control (normal saline) and relevant reference standard drugs. Docking analyses were also performed to assess possible protein–ligand interactions. Results: The test compounds were non-toxic at doses of 50, 100 and 150 mg/kg body weight, ip.
    [Show full text]